nitrendipine has been researched along with Heart Failure in 34 studies
Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacodynamics of felodipine were analyzed in patients with congestive heart failure in a randomized, double-blind, placebo-controlled study." | 9.06 | Plasma concentration-effect relationship of felodipine intravenously in patients with congestive heart failure. ( Dunselman, PH; Edgar, B; Kuntze, CE; Lie, KI; Scaf, AH; van Bruggen, A; Wesseling, H, 1989) |
| "The efficacy of felodipine, a vasodilating calcium antagonist, was analysed in 23 patients with congestive heart failure, New York Heart Association class III, during an 8-week, double-blind, randomized, placebo-controlled, parallel study." | 9.06 | Efficacy of felodipine in congestive heart failure. ( Dunselman, PH; Hamer, JP; Kuntze, CE; Lie, KI; Scaf, AH; van Bruggen, A; Wessling, H, 1989) |
| "The interaction between felodipine and digoxin was studied after a single oral dose and at steady state in 14 patients with congestive heart failure." | 9.06 | Effects of felodipine on plasma digoxin levels and haemodynamics in patients with heart failure. ( Aberg, J; Kirch, W; Laskowski, M; Ohnhaus, EE, 1989) |
| " In a randomized, parallel, double-blind study felodipine was administered to 11 and placebo to 12 patients with congestive heart failure." | 9.06 | Pharmacokinetics of felodipine after intravenous and chronic oral administration in patients with congestive heart failure. ( Dunselman, PH; Edgar, B; Kuntze, CE; Scaf, AH; Wesseling, H, 1989) |
| "A possible interaction between felodipine and digoxin was studied in 23 patients with congestive heart failure before and after 8 weeks treatment with both drugs." | 9.06 | Digoxin-felodipine interaction in patients with congestive heart failure. ( Dunselman, PH; Kuntze, CE; Lie, KI; Scaf, AH; Wesseling, H, 1988) |
| "Previous open studies have suggested that felodipine, a selective calcium antagonist and vasodilator, may be useful in the treatment of heart failure." | 9.06 | Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects. ( Littler, WA; Murray, RG; Tan, LB, 1987) |
| "A vascular selective calcium antagonist, felodipine, was evaluated in a randomised, double blind, crossover trial in 18 patients with chronic congestive heart failure of ischaemic cause." | 9.06 | Efficacy of felodipine in chronic congestive heart failure: a placebo controlled haemodynamic study at rest and during exercise and orthostatic stress. ( Amtorp, O; Fritz-Hansen, P; Kassis, E; Waldorff, S, 1987) |
| "The acute hemodynamic response to a single oral dose of nitrendipine (10-20 mg) was evaluated in eight subjects with severe chronic congestive heart failure during right heart catheterization." | 7.67 | Acute hemodynamic effects of nitrendipine in chronic congestive heart failure. ( Cohn, JN; Levine, TB; Olivari, MT, 1984) |
| " The combination of nitrendipine plus enalapril was also examined in ischemic failure and in rats with spontaneous hypertension." | 7.67 | Enalapril in experimental hypertension and acute heart failure: comparison with calcium channel blockers. ( Adkins, E; Emmert, S; Ludden, CT; Ribeiro, LG; Seymour, AA; Sweet, CS, 1986) |
| " To demonstrate the direct effect of nitrendipine, a 1,4 dihydropyridine, on LV performance, the acute hemodynamic response to oral nitrendipine was studied in 8 patients with congestive heart failure." | 7.67 | Calcium antagonists and left ventricular function: effects of nitrendipine in congestive heart failure. ( Cohn, JN, 1986) |
| " The efficacy of felodipine a new calcium channel blocker with selective vasodilator activity in the management of severe low output cardiac failure, secondary to coronary heart disease, was determined in 10 patients." | 7.67 | Sustained haemodynamic effects of felodipine in patients with chronic cardiac failure. ( Hutton, I; Martin, W; McGhie, AI; Tweddel, AC, 1988) |
| "The acute and long term central haemodynamic effects of felodipine were studied in 9 patients with severe congestive heart failure (NYHA III-IV)." | 7.67 | Haemodynamic effects of felodipine in congestive heart failure. ( Held, P; Swedberg, K, 1987) |
| "Studies in patients with congestive heart failure (CHF) have demonstrated an abnormal beta-adrenergic reflex vasodilation during orthostatic tilt." | 6.66 | Cardiovascular and neurohumoral postural responses and baroreceptor abnormalities during a course of adjunctive vasodilator therapy with felodipine for congestive heart failure. ( Amtorp, O; Kassis, E, 1987) |
| "Felodipine is a new dihydropyridine calcium antagonist drug with cardiovascular effects, whose pharmacokinetics and effects on plasma digoxin levels have been studied in patients with left ventricular failure." | 6.66 | Pharmacokinetics of felodipine and effect on digoxin plasma levels in patients with heart failure. ( Billing, E; Lundman, T; Moberg, L; Olsson, G; Rehnqvist, N, 1987) |
| "Peak and trough concentrations after 8 weeks oral therapy with felodipine, a vasodilating calcium antagonist of the dihydropyridine group, were predicted from intravenous pharmacokinetic data before therapy in 11 patients, randomly allocated to felodipine treatment 10 mg b." | 5.28 | Oral pharmacokinetics of felodipine in patients with congestive heart failure: variable prediction using intravenous data. ( Dunselman, PH; Scaf, AH; Wesseling, H, 1989) |
| "A possible interaction between felodipine and digoxin was studied in 23 patients with congestive heart failure before and after 8 weeks treatment with both drugs." | 5.06 | Digoxin-felodipine interaction in patients with congestive heart failure. ( Dunselman, PH; Kuntze, CE; Lie, KI; Scaf, AH; Wesseling, H, 1988) |
| "The pharmacodynamics of felodipine were analyzed in patients with congestive heart failure in a randomized, double-blind, placebo-controlled study." | 5.06 | Plasma concentration-effect relationship of felodipine intravenously in patients with congestive heart failure. ( Dunselman, PH; Edgar, B; Kuntze, CE; Lie, KI; Scaf, AH; van Bruggen, A; Wesseling, H, 1989) |
| "The efficacy of felodipine, a vasodilating calcium antagonist, was analysed in 23 patients with congestive heart failure, New York Heart Association class III, during an 8-week, double-blind, randomized, placebo-controlled, parallel study." | 5.06 | Efficacy of felodipine in congestive heart failure. ( Dunselman, PH; Hamer, JP; Kuntze, CE; Lie, KI; Scaf, AH; van Bruggen, A; Wessling, H, 1989) |
| "The interaction between felodipine and digoxin was studied after a single oral dose and at steady state in 14 patients with congestive heart failure." | 5.06 | Effects of felodipine on plasma digoxin levels and haemodynamics in patients with heart failure. ( Aberg, J; Kirch, W; Laskowski, M; Ohnhaus, EE, 1989) |
| " In a randomized, parallel, double-blind study felodipine was administered to 11 and placebo to 12 patients with congestive heart failure." | 5.06 | Pharmacokinetics of felodipine after intravenous and chronic oral administration in patients with congestive heart failure. ( Dunselman, PH; Edgar, B; Kuntze, CE; Scaf, AH; Wesseling, H, 1989) |
| "Previous open studies have suggested that felodipine, a selective calcium antagonist and vasodilator, may be useful in the treatment of heart failure." | 5.06 | Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects. ( Littler, WA; Murray, RG; Tan, LB, 1987) |
| "A vascular selective calcium antagonist, felodipine, was evaluated in a randomised, double blind, crossover trial in 18 patients with chronic congestive heart failure of ischaemic cause." | 5.06 | Efficacy of felodipine in chronic congestive heart failure: a placebo controlled haemodynamic study at rest and during exercise and orthostatic stress. ( Amtorp, O; Fritz-Hansen, P; Kassis, E; Waldorff, S, 1987) |
| "A recently proposed analytical technique to determine whether an inotropic agent improves cardiac pumping performance via its vasodilatory or its positive inotropic effects was adopted to evaluate the pharmacological properties of a positive inotropic agent, dobutamine, and a vasodilatory calcium antagonist, felodipine, in patients with severe heart failure." | 5.06 | An analytical method to separate inotropic and vasodilatory drug effects in patients with heart failure. ( Littler, WA; Murray, RG; Tan, LB, 1987) |
| " We compared the effects of benidipine, which has beneficial cardiac effects, and nitrendipine, which does not, in an animal model of hypertensive diastolic heart failure (DHF)." | 3.76 | Ca(2+) channel blocker benidipine promotes coronary angiogenesis and reduces both left-ventricular diastolic stiffness and mortality in hypertensive rats. ( Cheng, XW; Hirashiki, A; Izawa, H; Jin, Z; Kuzuya, M; Murohara, T; Nagata, K; Nishizawa, T; Noda, A; Obata, K; Okumura, K; Sasaki, T; Shi, GP; Takeshita, K, 2010) |
| " To demonstrate the direct effect of nitrendipine, a 1,4 dihydropyridine, on LV performance, the acute hemodynamic response to oral nitrendipine was studied in 8 patients with congestive heart failure." | 3.67 | Calcium antagonists and left ventricular function: effects of nitrendipine in congestive heart failure. ( Cohn, JN, 1986) |
| "The acute hemodynamic response to a single oral dose of nitrendipine (10-20 mg) was evaluated in eight subjects with severe chronic congestive heart failure during right heart catheterization." | 3.67 | Acute hemodynamic effects of nitrendipine in chronic congestive heart failure. ( Cohn, JN; Levine, TB; Olivari, MT, 1984) |
| " The combination of nitrendipine plus enalapril was also examined in ischemic failure and in rats with spontaneous hypertension." | 3.67 | Enalapril in experimental hypertension and acute heart failure: comparison with calcium channel blockers. ( Adkins, E; Emmert, S; Ludden, CT; Ribeiro, LG; Seymour, AA; Sweet, CS, 1986) |
| " The efficacy of felodipine a new calcium channel blocker with selective vasodilator activity in the management of severe low output cardiac failure, secondary to coronary heart disease, was determined in 10 patients." | 3.67 | Sustained haemodynamic effects of felodipine in patients with chronic cardiac failure. ( Hutton, I; Martin, W; McGhie, AI; Tweddel, AC, 1988) |
| "The acute and long term central haemodynamic effects of felodipine were studied in 9 patients with severe congestive heart failure (NYHA III-IV)." | 3.67 | Haemodynamic effects of felodipine in congestive heart failure. ( Held, P; Swedberg, K, 1987) |
| "In conclusion, in patients with chronic cardiac failure, treatment with a calcium channel blocker produced sustained haemodynamic improvement, particularly on exercise, and combination with nitrate produced further benefit." | 2.66 | Calcium channel blocker and isosorbide 5-mononitrate in the management of chronic cardiac failure. ( Hutton, I; Martin, W; McGhie, AI; Tweddel, AC, 1987) |
| "Felodipine is a new dihydropyridine calcium antagonist drug with cardiovascular effects, whose pharmacokinetics and effects on plasma digoxin levels have been studied in patients with left ventricular failure." | 2.66 | Pharmacokinetics of felodipine and effect on digoxin plasma levels in patients with heart failure. ( Billing, E; Lundman, T; Moberg, L; Olsson, G; Rehnqvist, N, 1987) |
| "Studies in patients with congestive heart failure (CHF) have demonstrated an abnormal beta-adrenergic reflex vasodilation during orthostatic tilt." | 2.66 | Cardiovascular and neurohumoral postural responses and baroreceptor abnormalities during a course of adjunctive vasodilator therapy with felodipine for congestive heart failure. ( Amtorp, O; Kassis, E, 1987) |
| "In this mouse model of dilated cardiomyopathy leading to sudden arrhythmic death, cardiac structure and function did not significantly differ among the control, cilnidipine, and nitrendipine groups." | 1.40 | Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure. ( Arai, Y; Cho, K; Kamakura, S; Kangawa, K; Kimura, T; Kinoshita, H; Kiyonaka, S; Kuwabara, Y; Kuwahara, K; Minami, T; Mori, Y; Nakagawa, Y; Nakao, K; Nishida, M; Nishikimi, T; Shibata, J; Ueshima, K; Yamada, C; Yamada, Y; Yasuno, S, 2014) |
| "The development of congestive heart failure (CHF) is accompanied by left ventricular (LV) and myocyte contractile dysfunction." | 1.30 | Changes in L-type calcium channel abundance and function during the transition to pacing-induced congestive heart failure. ( Basler, CG; Hewett, KW; Mukherjee, R; Spinale, FG; Walker, JD, 1998) |
| "Peak and trough concentrations after 8 weeks oral therapy with felodipine, a vasodilating calcium antagonist of the dihydropyridine group, were predicted from intravenous pharmacokinetic data before therapy in 11 patients, randomly allocated to felodipine treatment 10 mg b." | 1.28 | Oral pharmacokinetics of felodipine in patients with congestive heart failure: variable prediction using intravenous data. ( Dunselman, PH; Scaf, AH; Wesseling, H, 1989) |
| "Heart failure was induced by three to seven, graded, sequential, intracoronary microembolizations performed 1 to 3 weeks apart." | 1.28 | Myocardial beta adrenoceptor and voltage sensitive calcium channel changes in a canine model of chronic heart failure. ( Gengo, PJ; Goldstein, S; Kono, T; Sabbah, HN; Sharpe, JK; Steffen, RP; Stein, PD, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (64.71) | 18.7374 |
| 1990's | 7 (20.59) | 18.2507 |
| 2000's | 2 (5.88) | 29.6817 |
| 2010's | 3 (8.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, Y | 1 |
| Kinoshita, H | 1 |
| Kuwahara, K | 1 |
| Nakagawa, Y | 1 |
| Kuwabara, Y | 1 |
| Minami, T | 1 |
| Yamada, C | 1 |
| Shibata, J | 1 |
| Nakao, K | 2 |
| Cho, K | 1 |
| Arai, Y | 1 |
| Yasuno, S | 1 |
| Nishikimi, T | 1 |
| Ueshima, K | 1 |
| Kamakura, S | 1 |
| Nishida, M | 1 |
| Kiyonaka, S | 1 |
| Mori, Y | 1 |
| Kimura, T | 1 |
| Kangawa, K | 1 |
| Thijs, L | 1 |
| Richart, T | 1 |
| de Leeuw, PW | 2 |
| Kuznetsova, T | 1 |
| Grodzicki, T | 1 |
| Kawecka-Jaszcz, K | 1 |
| O'Brien, E | 2 |
| Redón, J | 1 |
| Birkenhäger, WH | 2 |
| Fagard, R | 2 |
| Staessen, JA | 2 |
| Nishizawa, T | 1 |
| Cheng, XW | 1 |
| Jin, Z | 1 |
| Obata, K | 1 |
| Nagata, K | 1 |
| Hirashiki, A | 1 |
| Sasaki, T | 1 |
| Noda, A | 1 |
| Takeshita, K | 1 |
| Izawa, H | 1 |
| Shi, GP | 1 |
| Kuzuya, M | 1 |
| Okumura, K | 1 |
| Murohara, T | 1 |
| Thijisq, L | 1 |
| Celis, H | 1 |
| Bulpitt, CJ | 1 |
| Fletcher, AE | 1 |
| Forette, F | 1 |
| Leonetti, G | 1 |
| McCormack, P | 1 |
| Nachev, C | 1 |
| Rodicio, JL | 1 |
| Rosenfeld, J | 1 |
| Sarti, C | 1 |
| Tuomilehto, J | 1 |
| Webster, J | 1 |
| Yodfat, Y | 1 |
| Zanchetti, A | 1 |
| Olivari, MT | 1 |
| Levine, TB | 1 |
| Cohn, JN | 2 |
| Colston, JT | 1 |
| Kumar, P | 1 |
| Chambers, JP | 1 |
| Freeman, GL | 1 |
| Zhao, LY | 1 |
| Cao, SP | 1 |
| Mukherjee, R | 1 |
| Hewett, KW | 1 |
| Walker, JD | 1 |
| Basler, CG | 1 |
| Spinale, FG | 1 |
| Gengo, PJ | 1 |
| Sabbah, HN | 1 |
| Steffen, RP | 1 |
| Sharpe, JK | 1 |
| Kono, T | 1 |
| Stein, PD | 1 |
| Goldstein, S | 1 |
| Müller, R | 1 |
| Steffen, HM | 1 |
| Kugel, C | 1 |
| Freiheit, T | 1 |
| Franzen, D | 1 |
| Wambach, G | 1 |
| Kaufmann, W | 1 |
| Schwinger, RH | 1 |
| Böhm, M | 1 |
| Erdmann, E | 1 |
| Dixon, IM | 1 |
| Lee, SL | 1 |
| Dhalla, NS | 1 |
| Sweet, CS | 1 |
| Ludden, CT | 1 |
| Adkins, E | 1 |
| Seymour, AA | 1 |
| Emmert, S | 1 |
| Ribeiro, LG | 1 |
| Finkel, MS | 1 |
| Marks, ES | 1 |
| Patterson, RE | 1 |
| Speir, EH | 1 |
| Steadman, KA | 1 |
| Keiser, HR | 1 |
| Dunselman, PH | 6 |
| Edgar, B | 2 |
| Scaf, AH | 5 |
| Kuntze, CE | 5 |
| van Bruggen, A | 3 |
| Lie, KI | 4 |
| Wesseling, H | 4 |
| Hamer, JP | 1 |
| Wessling, H | 1 |
| Kirch, W | 1 |
| Laskowski, M | 1 |
| Ohnhaus, EE | 1 |
| Aberg, J | 1 |
| Kassis, E | 3 |
| Amtorp, O | 3 |
| Barbieri, L | 1 |
| Mestroni, L | 1 |
| Camerini, F | 1 |
| Tweddel, AC | 2 |
| Martin, W | 2 |
| McGhie, AI | 2 |
| Hutton, I | 2 |
| Tan, LB | 2 |
| Murray, RG | 2 |
| Littler, WA | 2 |
| Waldorff, S | 2 |
| Fritz-Hansen, P | 1 |
| Rehnqvist, N | 1 |
| Billing, E | 1 |
| Moberg, L | 1 |
| Lundman, T | 1 |
| Olsson, G | 1 |
| Held, P | 1 |
| Swedberg, K | 1 |
| Lossnitzer, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Stroke Prediction Study Using a Model Based on Internet Search Queries[NCT04755959] | 450 participants (Anticipated) | Observational | 2021-02-28 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for nitrendipine and Heart Failure
| Article | Year |
|---|---|
[Calcium antagonists in congestive heart failure].
Topics: Calcium Channel Blockers; Cardiomyopathy, Dilated; Diltiazem; Felodipine; Heart Failure; Hemodynamic | 1988 |
15 trials available for nitrendipine and Heart Failure
| Article | Year |
|---|---|
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus; Dihydrop | 2004 |
[Different changes in the adrenergic system with nitrendipine and captopril and different therapeutic aspects in treatment of hypertension and heart failure].
Topics: Adult; Captopril; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Midd | 1991 |
Plasma concentration-effect relationship of felodipine intravenously in patients with congestive heart failure.
Topics: Aged; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Felodipine; Fem | 1989 |
Efficacy of felodipine in congestive heart failure.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Felodipine; Female; Heart Failur | 1989 |
Effects of felodipine on plasma digoxin levels and haemodynamics in patients with heart failure.
Topics: Aged; Calcium Channel Blockers; Clinical Trials as Topic; Digoxin; Felodipine; Female; Heart Failure | 1989 |
Pharmacokinetics of felodipine after intravenous and chronic oral administration in patients with congestive heart failure.
Topics: Administration, Oral; Aged; Calcium Channel Blockers; Cardiac Output; Clinical Trials as Topic; Doub | 1989 |
Cardiovascular and neurohumoral postural responses and baroreceptor abnormalities during a course of adjunctive vasodilator therapy with felodipine for congestive heart failure.
Topics: Aged; Cardiovascular System; Clinical Trials as Topic; Double-Blind Method; Epinephrine; Felodipine; | 1987 |
Digoxin-felodipine interaction in patients with congestive heart failure.
Topics: Aged; Clinical Trials as Topic; Digoxin; Double-Blind Method; Drug Interactions; Drug Therapy, Combi | 1988 |
Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects.
Topics: Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Echocardiography; Exercise Tes | 1987 |
Efficacy of felodipine in chronic congestive heart failure: a placebo controlled haemodynamic study at rest and during exercise and orthostatic stress.
Topics: Adult; Aged; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Felodipine; Fe | 1987 |
Felodipine in heart failure. A double-blind, randomised, placebo-controlled parallel-group study in 23 patients.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Felodipine; Heart Failure; H | 1987 |
Pharmacokinetics of felodipine and effect on digoxin plasma levels in patients with heart failure.
Topics: Aged; Antihypertensive Agents; Digoxin; Felodipine; Female; Heart Failure; Humans; Male; Middle Aged | 1987 |
Haemodynamic effects of felodipine during supine resting and exercising states and orthostatic tilt in patients with chronic congestive heart failure.
Topics: Antihypertensive Agents; Chronic Disease; Felodipine; Heart Failure; Hemodynamics; Humans; Nitrendip | 1987 |
An analytical method to separate inotropic and vasodilatory drug effects in patients with heart failure.
Topics: Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Felodipine; Female; Heart Failure; Heart Funct | 1987 |
Calcium channel blocker and isosorbide 5-mononitrate in the management of chronic cardiac failure.
Topics: Chronic Disease; Coronary Disease; Drug Therapy, Combination; Exercise Test; Felodipine; Heart Failu | 1987 |
18 other studies available for nitrendipine and Heart Failure
| Article | Year |
|---|---|
Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nervou | 2014 |
Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug T | 2010 |
Ca(2+) channel blocker benidipine promotes coronary angiogenesis and reduces both left-ventricular diastolic stiffness and mortality in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Coronary Circulation; Diastole; Dihydrop | 2010 |
Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Topics: Adult; Aged; Calcium Channel Blockers; Cardiac Output; Chronic Disease; Female; Forearm; Heart Failu | 1984 |
Altered sarcolemmal calcium channel density and Ca(2+)-pump ATPase activity in tachycardia heart failure.
Topics: Animals; Calcium; Calcium Channels; Calcium-Transporting ATPases; Cardiac Pacing, Artificial; Enzyme | 1994 |
[The changes in plasma arginine-vasopressin in patients with essential hypertension and the correlation with patient's condition].
Topics: Adult; Aged; Arginine Vasopressin; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ve | 1993 |
Changes in L-type calcium channel abundance and function during the transition to pacing-induced congestive heart failure.
Topics: Adrenergic beta-Agonists; Animals; Calcium Channel Blockers; Calcium Channels; Cardiac Pacing, Artif | 1998 |
[Innovation, step innovation, Me too. Are calcium antagonists interchangeable?].
Topics: Aged; Amlodipine; Calcium Channel Blockers; Delayed-Action Preparations; Heart Failure; Humans; Hype | 2001 |
Myocardial beta adrenoceptor and voltage sensitive calcium channel changes in a canine model of chronic heart failure.
Topics: Animals; Calcium Channels; Dihydroalprenolol; Disease Models, Animal; Dogs; Down-Regulation; Heart F | 1992 |
Different negative inotropic activity of Ca2(+)-antagonists in human myocardial tissue.
Topics: Calcium Channel Blockers; Depression, Chemical; Diltiazem; Heart Atria; Heart Failure; Heart Transpl | 1990 |
Nitrendipine binding in congestive heart failure due to myocardial infarction.
Topics: Animals; Binding Sites; Binding, Competitive; Calcium Channel Blockers; Calcium Channels; Heart Fail | 1990 |
Enalapril in experimental hypertension and acute heart failure: comparison with calcium channel blockers.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; D | 1986 |
Correlation of changes in cardiac calcium channels with hemodynamics in Syrian hamster cardiomyopathy and heart failure.
Topics: Animals; Body Weight; Calcium; Cardiomyopathies; Cricetinae; Heart Failure; Hemodynamics; Humans; In | 1987 |
Oral pharmacokinetics of felodipine in patients with congestive heart failure: variable prediction using intravenous data.
Topics: Administration, Oral; Aged; Calcium Channel Blockers; Double-Blind Method; Felodipine; Female; Heart | 1989 |
Calcium antagonists and left ventricular function: effects of nitrendipine in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Heart Failure; Hemodynamics; Humans; Myocardi | 1986 |
Sustained haemodynamic effects of felodipine in patients with chronic cardiac failure.
Topics: Adult; Blood Pressure; Exercise; Felodipine; Female; Heart Failure; Hemodynamics; Humans; Male; Midd | 1988 |
Haemodynamic effects of felodipine in congestive heart failure.
Topics: Adult; Aged; Antihypertensive Agents; Felodipine; Female; Heart Failure; Hemodynamics; Humans; Male; | 1987 |
[Effect and benefit of afterload reduction in coronary heart disease].
Topics: Coronary Disease; Heart Failure; Heart Ventricles; Humans; Nitrendipine; Vasodilator Agents | 1987 |